Home  »  Industry   »  MYGN’s Stock Market Adventure: 56.31% YTD Gr...

MYGN’s Stock Market Adventure: 56.31% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 56.31% this year. Over the last six months, there has been a weaker performance of 19.24%. The price of MYGN fallen by 3.70% during the last 30 days period. For the last 5-days stocks have improved 22.00%.

Myriad Genetics Inc. (MYGN) has a current stock price of $22.68. During the previous trading session, the stock witnessed a notable rise, reaching a high of $23.2465 after opening at $21.97. The stock’s low for the day was $21.857, and it eventually closed at $20.07.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Myriad Genetics Inc. had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $28.18 on 08/11/22, while the lowest price during the same period was $13.92 on 12/30/22.

52-week price history of MYGN Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Myriad Genetics Inc.’s current trading price is -19.52% away from its 52-week high, while its distance from the 52-week low is 62.93%. The stock’s price range over this timeframe has been between $13.92 and $28.18. The shares of the Healthcare sector company recorded a trading volume of approximately 0.86 million for the day, which was comparatively higher than the average daily volume of 0.61 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Myriad Genetics Inc. (MYGN) has experienced a quarterly rise of 22.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.79B and boasts a workforce of 2600 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 20.45, with a change in price of +8.12. Similarly, Myriad Genetics Inc. recorded 637,997 in trading volume during the last 100 days, posting a change of +55.77%.

MYGN’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for MYGN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

MYGN Stock Stochastic Average

Myriad Genetics Inc.’s raw stochastic average for the past 50 days is currently at 79.58%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 90.41%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 61.07% and 43.74%, respectively.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts